Literature DB >> 7582044

Human prion diseases.

P Parchi1, P Gambetti.   

Abstract

Major advances have been made in prion diseases. Recent data indicate that the prion protein is likely to be a synaptic protein with a functional role in synaptic transmission. An impressive body of evidence suggests that (1) the normal prion protein plays a central role in prion replication; (2) the replication process implies an interaction between the normal prion protein and the pathogenic prion protein; and (3) the pathogenic prion protein is the infectious agent, the infectivity of which is dependent on its abnormal conformation. Genetic and protein analyses have expanded the spectrum of prion diseases and have underlined the complexity of genotype-phenotype interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582044     DOI: 10.1097/00019052-199508000-00007

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  12 in total

1.  Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Authors:  N Nishida; D A Harris; D Vilette; H Laude; Y Frobert; J Grassi; D Casanova; O Milhavet; S Lehmann
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures.

Authors:  A Mangé; N Nishida; O Milhavet; H E McMahon; D Casanova; S Lehmann
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Conserved amyloid core structure of stop mutants of the human prion protein.

Authors:  Markus Zweckstetter
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

4.  Characterization and enzymatic degradation of Sup35NM, a yeast prion-like protein.

Authors:  Ching-Ying Chen; Kawan Rojanatavorn; A Clay Clark; Jason C H Shih
Journal:  Protein Sci       Date:  2005-08-04       Impact factor: 6.725

Review 5.  Cellular biology of prion diseases.

Authors:  D A Harris
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

6.  Ancestral origins of the prion protein gene D178N mutation in the Basque Country.

Authors:  Ana B Rodríguez-Martínez; Christian Barreau; Isabelle Coupry; Jordi Yagüe; Raquel Sánchez-Valle; Luis Galdós-Alcelay; Agustín Ibáñez; Antón Digón; Ignacio Fernández-Manchola; Cyril Goizet; Azucena Castro; Nerea Cuevas; Maite Alvarez-Alvarez; Marian M de Pancorbo; Benoît Arveiler; Juan J Zarranz
Journal:  Hum Genet       Date:  2005-04-02       Impact factor: 4.132

7.  Genetic influence on the structural variations of the abnormal prion protein.

Authors:  P Parchi; W Zou; W Wang; P Brown; S Capellari; B Ghetti; N Kopp; W J Schulz-Schaeffer; H A Kretzschmar; M W Head; J W Ironside; P Gambetti; S G Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures.

Authors:  Kazuhiko Arima; Noriyuki Nishida; Suehiro Sakaguchi; Kazuto Shigematsu; Ryuichiro Atarashi; Naohiro Yamaguchi; Daisuke Yoshikawa; Jaewoo Yoon; Ken Watanabe; Nobuyuki Kobayashi; Sophie Mouillet-Richard; Sylvain Lehmann; Shigeru Katamine
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.

Authors:  Cristina Casalone; Gianluigi Zanusso; Pierluigi Acutis; Sergio Ferrari; Lorenzo Capucci; Fabrizio Tagliavini; Salvatore Monaco; Maria Caramelli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

10.  Mutations at codons 178, 200-129, and 232 contributed to the inherited prion diseases in Korean patients.

Authors:  Bo-Yeong Choi; Su Yeon Kim; So-Young Seo; Seong Soo A An; Sangyun Kim; Sang-Eun Park; Seung-Han Lee; Yun-Ju Choi; Sang-Jin Kim; Chi-Kyeong Kim; Jun-Sun Park; Young-Ran Ju
Journal:  BMC Infect Dis       Date:  2009-08-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.